56 medical projects won the China Patent Award, involving 68 pharmaceutical companies

On December 26, the State Intellectual Property Office issued the “Decision on the Award of the 19th China Patent Award”. According to relevant statistics, there are 56 projects in the pharmaceutical industry, involving a total of 68 pharmaceutical companies. The awards include the China Patent Gold Award, the China Patent Silver Award, and the China Patent Excellence Award. Among them, three medical projects won the China Patent Gold Award.

Imidazole-5-carboxylic acid derivative, preparation method and application thereof

The patentees of the medical project are Shenzhen Xinlitai Pharmaceutical Co., Ltd. and Huizhou Xinlitai Pharmaceutical Co., Ltd., and the inventors are Guo Jianhui and Anton.

Shenzhen Xinlitai Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical group integrating research, development, production and sales of pharmaceutical products. Xinlitai is the core competitiveness of innovative products and evidence-based medicine promotion, and maintains the leading edge of cardiovascular and cerebrovascular high-end medicines. At the same time, it expands the target areas such as blood sugar lowering, anti-tumor, orthopedics and anti-infection, and rapidly enriches the product line through independent research and development, technical cooperation, investment and mergers and acquisitions, and develops several heavy products.

Huizhou Xinlitai Pharmaceutical Excessive Co., Ltd. is a subsidiary of Shenzhen Xinlitai Pharmaceutical Co., Ltd. It is a high-end biomedical production enterprise integrating R&D, production and sales. It is committed to cardiovascular, anti-diabetic and anti-tumor. The development and production of anti-infective APIs, building a product group around cardiovascular and cerebrovascular diseases.

Preparation method of continuous stable vitamin A microcapsule

The patentees of the medical project are Zhejiang University, Zhejiang Xinhecheng Co., Ltd. and Beijing University of Chemical Technology. The inventors are Yin Hong, Chen Jianfeng, Chen Zhirong, Wang Jiexin, Qi Yong, Zhao Hong, Shi Lifang and Qiu Dan.

Since its establishment in 1999, Zhejiang Xinhecheng Co., Ltd. has always focused on fine chemicals, adhere to the innovation-driven and balanced, sustainable development concept, in the fields of nutrients, flavors and fragrances, APIs, and new polymer materials.

Over the years, Zhejiang Xinhecheng Co., Ltd. has provided solutions for animal nutrition, human nutrition, medicine, life health, environmental protection, engineering plastics, etc. for customers in more than 100 countries and regions around the world, thus using health and environmental protection. Products continue to improve the quality of human life and create value for stakeholders.

A strain of Paecilomyces sinensis and application thereof

The patentee of the medical project is Zhejiang Pan Asia Bio-Pharmaceutical Co., Ltd., and the inventors are Chen Zhuan, Sun Changsheng, Zhao Wei and Li Cheng.

Zhejiang Pan Asia Bio-Pharmaceutical Co., Ltd. is mainly engaged in the systematic research and application development of Cordyceps fungi resources, focusing on the promotion of traditional Chinese medicine Cordyceps including Cordyceps militaris, Cordyceps militaris, Coccidella and Cordyceps sinensis fermentation products. Fungal inheritance, industrial modernization and internationalization.

Zhejiang Pan Asia Bio-Pharmaceutical Co., Ltd. is a state-level high-tech enterprise in the field of Cordyceps fungi, from basic research to industrial transformation, covering biotechnology and medical health.

Conclusion:

In addition to the above three patent gold awards, Guangdong Huanan Pharmaceutical Group Co., Ltd. "treatment of stroke drugs and preparation methods", Hays Moore Biotechnology Co., Ltd. "medical chitosan fiber and its preparation method" and other four projects Received the China Patent Silver Award.

Shenzhen Taitai Pharmaceutical Co., Ltd. "a traditional Chinese medicine preparation for treating women with menopausal syndrome", "A drug for the treatment of osteoporosis" by Guangdong Anuo Pharmaceutical Co., Ltd., and Qilu Pharmaceutical (Hainan) Co., Ltd. "Dexidazide lyophilized preparation and its preparation method", Shanghai Pharmaceutical Group Qingdao Guofeng Pharmaceutical Co., Ltd. "a preparation process of Polysaccharide iron complex and its quality testing method" and other 49 projects obtained Chinese patents Excellence Award.

Natural Plant Pigment

Natural Plant Pigment,Plant Pigments,Natural Pigments,Plant Based Pigments

Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyibiology.com

Posted on